Don't want ads? Subscribe or login now.

ImClone Settles Patent Row With Yeda, Sanofi

By Jacqueline Bell · December 7, 2007, 12:00 AM EST

Biotech company ImClone Systems Inc. has inked a settlement agreement with Yeda Research and Development Company Ltd. and Sanofi-Aventis, putting to rest a patent dispute related to the cancer drug Erbitux,...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Jacqueline

August 23, 2022
These Firms Have The Most Women In Equity Partnerships
August 22, 2022
A Deep Dive Into The Glass Ceiling Report: Women In Law
July 26, 2022
These Law Firms Have The Most Diverse Equity Partnerships
July 25, 2022
Law360's Diversity Snapshot: What You Need To Know
June 20, 2022
The Law360 400: Tracking The Largest US Law Firms
January 26, 2022
Justice Breyer To Retire From High Court
November 01, 2021
As Social Impact Becomes The Test, Firms Asked To Step Up
September 14, 2021
These Firms Have The Most Women In Equity Partnerships
September 13, 2021
Law360's Glass Ceiling Report: What You Need To Know
August 17, 2021
These Law Firms Have The Most Diverse Equity Partnerships

ImClone Settles Patent Row With Yeda, Sanofi

Related Sections

Recent Articles By Jacqueline